PainChek's Milestones and Future Plans
PainChek CEO & Managing Director Philip Daffas, recently gave an update to…
PainChek CEO Philip Daffas talks with Dementia Centre
We are the world’s first smartphone pain assessment and monitoring…
National roll out of PainChek® with Dementia Support Australia (DSA) follows successful pilot
The Dementia Support Australia (DSA) “PainChek® in Practice” pilot study from…
New peer-reviewed publication confirms accuracy and clinical utility of PainChek®
New study published in the Journal of Pain Research on PainChek® confirms its…
Dr Jennifer Abbey joins PainChek Clinical Advisory Board
Dr Abbey is the developer and innovator behind the Abbey Pain Scale (APS) which…
PainChek's Managing Director and CEO Philip Daffas talks to Finance News Network
Philip Daffas talks to Jessica Amir on how PainChek works, the business model…
PainChek wins 2018 Good Design Award®
Australia’s Good Design Awards, the highest honour for design innovation…
PainChek to secure FDA De Novo classification
Formerly ePat Technologies (ASX: EPT), medical device company PainChek (ASX:…
PainChek signs commercial agreement with leading ANZ software system provider Health Metrics
Highlights: • Commercial agreement with Health Metrics, a market leader in…
